BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Clinical Outcome
14 results:

  • 1. Low abundance of TFPI-2 by both promoter methylation and miR-27a-3p regulation is linked with poor clinical outcome in gastric cancer.
    Geng G; Liu X; Xu A; Lu Z; Chen K; He J; Qi D; Yuan X
    J Gene Med; 2020 May; 22(5):e3166. PubMed ID: 31984574
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer in a Chinese population.
    Li J; Zuo X; Lv X; Kong F; Xu W; Yang S
    Tumour Biol; 2014 Aug; 35(8):7569-74. PubMed ID: 24793015
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological and molecular aspects of foregut gastrointestinal stromal tumours.
    Chen J; Gundara JS; Haddad R; Schiavone V; Meldrum C; Samra JS; Gill AJ; Hugh TJ
    ANZ J Surg; 2014; 84(1-2):52-8. PubMed ID: 23171083
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Distinct gene expression-defined classes of gastrointestinal stromal tumor.
    Yamaguchi U; Nakayama R; Honda K; Ichikawa H; Hasegawa T; Shitashige M; Ono M; Shoji A; Sakuma T; Kuwabara H; Shimada Y; Sasako M; Shimoda T; Kawai A; Hirohashi S; Yamada T
    J Clin Oncol; 2008 Sep; 26(25):4100-8. PubMed ID: 18757323
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gastrointestinal stromal tumors (GIST) of the stomach: retrospective experience with surgical resection at the National cancer Institute.
    Naguib SF; Zaghloul AS; El Marakby H
    J Egypt Natl Canc Inst; 2008 Mar; 20(1):80-9. PubMed ID: 19847285
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery.
    Galizia G; Lieto E; Orditura M; Castellano P; Mura AL; Imperatore V; Pinto M; Zamboli A; De Vita F; Ferraraccio F
    World J Surg; 2007 Jul; 31(7):1458-68. PubMed ID: 17516110
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognosis of gastrointestinal stromal tumors.
    Bertin M; Angriman I; Scarpa M; Mencarelli R; Ranzato R; Ruffolo C; Polese L; Iacobone M; D'Amico DF
    Hepatogastroenterology; 2007; 54(73):124-8. PubMed ID: 17419245
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Expression of p53 and BCI-2 as prognostic markers and for anatomical location in gastrointestinal stromal tumors (GIST). Clinico-pathological and immunohistochemistry study of 19 cases].
    Martínez-Consuegra N; Baquera-Heredia J; de León-Bojorge B; Padilla-Rodríguez A; Hidalgo CO
    Rev Gastroenterol Mex; 2006; 71(3):269-78. PubMed ID: 17140048
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
    Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A
    Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B; Sökmensüer C
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Relation between seroreactivity to low-molecular-weight Helicobacter pylori-specific antigens and disease presentation.
    Vilaichone RK; Mahachai V; Kositchaiwat C; Graham DY; Yamaoka Y
    Clin Diagn Lab Immunol; 2003 Nov; 10(6):1025-8. PubMed ID: 14607862
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Low molecular weight protein of Helicobacter pylori and its relation to gastroduodenal diseases.
    Kuo CH; Wu DC; Lu CY; Su YC; Yu FJ; Lee YC; Wu IC; Lin SR; Liu CS; Jan CM; Wang WM
    Hepatogastroenterology; 2003; 50(52):897-901. PubMed ID: 12845945
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Fine needle aspiration of gastrointestinal stromal tumors.
    Li SQ; O'Leary TJ; Buchner SB; Przygodzki RM; Sobin LH; Erozan YS; Rosenthal DL
    Acta Cytol; 2001; 45(1):9-17. PubMed ID: 11213513
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. kit mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors.
    Ernst SI; Hubbs AE; Przygodzki RM; Emory TS; Sobin LH; O'Leary TJ
    Lab Invest; 1998 Dec; 78(12):1633-6. PubMed ID: 9881963
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.